Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry
Abstract Background Limited real‐world studies are available comparing infection risk between biologics for psoriasis. Objectives The primary aim was to determine the differential effect of currently available biologics on the risk of respiratory tract infections (RTI) among psoriasis patients in a...
Saved in:
Main Authors: | Lara S. van derSchoot (Author), Hans J. M. M. Groenewoud (Author), Marleen M. H. J. vanGelder (Author), Marisol E. Otero (Author), W. Peter Arnold (Author), Maartje A. M. Berends (Author), Marjolein S. De Bruin‐Weller (Author), Sharon R. P. Dodemont (Author), Marloes M. Kleinpenning (Author), Marjolein I. A. Koetsier (Author), Else N. Kop (Author), John E. M. Körver (Author), Astrid L. A. Kuijpers (Author), Paula P. vanLümig (Author), Johannes M. Mommers (Author), Marcellus D. Njoo (Author), Paul M. Ossenkoppele (Author), Ron A. Tupker (Author), M. Birgitte Visch (Author), Lizelotte J. M. T. Weppner‐Parren (Author), Elke M. G. J. deJong (Author), Juul M. P. A. van denReek (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry
by: Tamara W. van Hal, et al.
Published: (2024) -
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
by: Marloes E. van Muijen, et al.
Published: (2022) -
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
by: Selma Atalay, et al.
Published: (2020) -
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
by: Juul M.P.A. van den Reek, et al.
Published: (2018) -
Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a review
by: C. A. M. van Riel, et al.
Published: (2024)